Biomarkers of Complement and Platelet Activation are not correlated with the One or Twenty-Four Hours Corrected Count Increments in Prophylactically Platelet Transfused Hematological Patients: a Prospective Cohort Study
Open Access
- 2 July 2021
- journal article
- research article
- Published by Taylor & Francis in Platelets
- Vol. 33 (3) , 350-359
Abstract
Platelet transfusion refractoriness is a serious clinical concern that complicates the management of thrombocytopenic patients. Previous studies have suggested a potential role for both complement and platelet activation based on in vitro analyses of platelet concentrates. In this study, the post-transfusion platelet response, as indicated by the corrected count increment at 1 and 24 h after prophylactic platelet transfusions, respectively, was correlated with the 1 h post-transfusion Δconcentration (1 h post-transfusion – pretransfusion) of complement and platelet activation biomarkers. The study was registered as a clinical trial at ClinicalTrials.gov (identifier: NCT02601131) and patients were recruited during inpatient care in the hematological department. Soluble terminal complement complexes, soluble P-selectin and soluble CD40 ligand were analyzed. Confirmed alloimmunized patients were excluded. Included subjects were either given platelet transfusions (n = 43) and categorized into four clinical study groups or included in a non-transfused control group (n = 10). In total, 54 transfusions were included. No transfusion-mediated complement activation was observed. The transfusions were associated with a significant increase in the concentration of soluble P-selectin (p < .001), primarily corresponding to the passive infusion of soluble P-selectin-containing plasma residuals. The Δconcentration of soluble P-selectin was, however, not significantly correlated with the corrected count increments. Thus, significant correlations between biomarkers of complement and platelet activation and the post-transfusion platelet response could not be demonstrated in this study.Keywords
Funding Information
- Clinical Research
- Swedish Government Funds (ALF and ST-ALF)
This publication has 37 references indexed in Scilit:
- The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopeniaBlood, 2012
- The investigation of platelet transfusion refractory in 69 malignant patients undergoing hematopoietic stem cell transplantationTransfusion and Apheresis Science, 2011
- Pooled platelet concentrates: An alternative to single donor apheresis platelets?Transfusion and Apheresis Science, 2009
- Platelet components associated with acute transfusion reactions: the role of platelet-derived soluble CD40 ligandBlood, 2008
- Complement and coagulation: strangers or partners in crime?Trends in Immunology, 2007
- PSGL-1 regulates platelet P-selectin-mediated endothelial activation and shedding of P-selectin from activated plateletsThrombosis and Haemostasis, 2007
- The expression of p‐selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viabilityTransfusion, 1997
- Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC)Clinical and Experimental Immunology, 1993
- Simplified Calculation of Body-Surface AreaNew England Journal of Medicine, 1987
- Indications for platelet transfusion in children with acute leukemiaAmerican Journal of Hematology, 1982